Sphinx Trading’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Sphinx Trading’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,000	Closed	-$241K	–	139
2016 Q2	$241K	Buy	+8,000	New	+$162K	0.48%	25

Sphinx Trading's CPXX Position: Q3 2016 in Review

Sphinx Trading sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 8,000 shares — an estimated $241K sold.

Sphinx Trading first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $241K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Sphinx Trading reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Sphinx Trading sold 8,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $241K.
Sphinx Trading first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Sphinx Trading's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $241K in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Sphinx Trading's 13F filing for Q3 2016, filed 24 Oct 2016.